// App-Quantinova.ai

: Protease activated receptor 2 (PAR2 antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells

Researchers

Presenter

  • Mariarca Bailo

Principal Investigators

  • L. Dunning

  • J. Brzeszczynska

  • K. Mcintosh

  • R. Plevin

  • S. L. Martin

  • G. P. Sergeant

  • C. S. Goodyear

  • G. S. Litherland

  • J. C. Lockhart

  • A. Crilly

Medical Centers

  • University of the West of England, Bristol, United Kingdom

  • University of Strathclyde, Glasgow, United Kingdom

  • Queen's University Belfast, Belfast, United Kingdom

  • Dundalk Institute of Technology, Dundalk, Ireland, Ireland

  • University of Glasgow, Glasgow, United Kingdom

Locations

  • United Kingdom

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Interleukin-8

  • Interleukin 6

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A